1Adams RD.A comparision of the morphology of the human demyelinating diseases and experimental "allergic" encephalomyelitis.In:Kie MW,Alvord EC,eds."Allergic" encephalomyelitis.Springfield:Charles C Thomas,1959.183-209.
2Miller A,Korem M,Almog R,et al.Vitamin B12,demyelination,remyelination and repair in multiple sclerosis.J Neurol Sci,2005,233:93-97.
4Chabriat H,Vahedi K,Iba-Zizen MT,et al.Clinical spectrum of CADASIL:a study of 7 families.Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy.Lancet,1995,346:934-939.
5Mehta RC,Pike GB,Enzmann DR.Measure of magnetization transfer in multiple sclerosis demyelinating plaques,white matter ischemic lesions,and edema.AJNR Am J Neuroradiol,1996,17:1051-1055.
6Lucchinetti C,Bruck W,Parisi J,et al.Heterogeneity of multiple sclerosis lesions:implications for the pathogenesis of demyelination.Ann Neurol,2000,47:707-717.
7Owens T.The enigma of multiple sclerosis:inflammation and neurodegeneration cause heterogeneous dysfunction and damage.Curr Opin Neurol,2003,16:259-265.
8Lucchinetti CF,Brück W,Rodriguez M,et al.Distinct patterns of multiple sclerosis pathology indicates heterogeneity on pathogenesis.Brain Pathol,1996,6:259-274.
9Lucchinetti C,Brück W,Parisi J,et al.A quantitative analysis of oligodendrocytes in multiple sclerosis lesions.A study of 113 cases.Brain,1999,122(Pt 12):2279-2295.
10Bruck W.Clinical implications of neuropathological findings in multiple sclerosis.J Neurol,2005,252 Suppl 3:iii10-iii14.
